Badalzadeh Reza, Mohammadi Mustafa, Yousefi Bahman, Farajnia Safar, Najafi Moslem, Mohammadi Shima
Department of Physiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Students' Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Adv Pharm Bull. 2015 Sep;5(3):321-7. doi: 10.15171/apb.2015.045. Epub 2015 Sep 19.
Diabetes mellitus as a main risk-factor of ischemic heart disease may interfere with postconditioning'scardioprotective effects. This study aimed to investigate the involvement of glycogen synthase kinase-3β (GSK-3β) and oxidation status in chronic diabetes-induced loss of cardioprotective effect of ischemic-postconditioning (IPostC) in Wistar rats.
After 8 weeks of induction of diabetes by streptozotocin (50mg/kg), hearts of control and diabetic rats were isolated and mounted on a constant-pressure Langendorff system. All hearts were subjected to 30min regional ischemia followed by 60min reperfusion (by occluding and re-opening of left anterior descending coronary artery, respectively). IPostC was applied immediately at the onset of reperfusion. At the end of reperfusion, the infarct size of myocardium was measured via computerized planimetry. Myocardial contents of malondealdehyde and glutathione as indices of oxidative status were assayed spectrophotometrically and the total and phosphorylated forms of myocardial GSK-3β were quantified through western blotting.
IPostC reduced the infarct size of control hearts from 41±2.9% to 28±1.9% (P<0.05), whereas it could not induce significant changes in infarct size of diabetic animals (35±1.8% vs. 39±3.1%). IPostC-induced reduction in malondealdehyde and elevation in glutathione contents were significant only in control not in diabetic hearts. The total forms of GSK-3β were similar in all groups; however, the phosphorylation of GSK-3β (at Ser9) by IPostC was greater in control hearts than diabetics (P<0.01).
The failure of cardioprotection by IPostC in diabetic hearts may be attributed to the loss of phosphorylation of GSK-3β and thereby increase in oxidative stress in diabetic states.
糖尿病作为缺血性心脏病的主要危险因素,可能会干扰缺血后处理的心脏保护作用。本研究旨在探讨糖原合酶激酶-3β(GSK-3β)和氧化状态在慢性糖尿病诱导的Wistar大鼠缺血后处理(IPostC)心脏保护作用丧失中的作用。
通过链脲佐菌素(50mg/kg)诱导糖尿病8周后,分离对照大鼠和糖尿病大鼠的心脏,并将其安装在恒压Langendorff系统上。所有心脏均经历30分钟的局部缺血,随后进行60分钟的再灌注(分别通过阻断和重新开放左前降支冠状动脉)。IPostC在再灌注开始时立即应用。再灌注结束时,通过计算机平面测量法测量心肌梗死面积。采用分光光度法测定丙二醛和谷胱甘肽的心肌含量作为氧化状态指标,并通过蛋白质印迹法定量心肌GSK-3β的总形式和磷酸化形式。
IPostC将对照心脏的梗死面积从41±2.9%降至28±1.9%(P<0.05),而对糖尿病动物的梗死面积无显著影响(35±1.8%对39±3.1%)。IPostC诱导的丙二醛减少和谷胱甘肽含量升高仅在对照心脏中显著,而在糖尿病心脏中不显著。所有组中GSK-3β的总形式相似;然而,IPostC对GSK-3β(丝氨酸9位点)的磷酸化在对照心脏中比糖尿病心脏中更大(P<0.01)。
糖尿病心脏中IPostC心脏保护作用的失败可能归因于GSK-3β磷酸化的丧失,从而导致糖尿病状态下氧化应激增加。